Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors
- Conditions
- Early Gastric CancerBarrett Esophagus
- Interventions
- Diagnostic Test: Linked Color ImagingDiagnostic Test: White Light Imaging
- Registration Number
- NCT03990025
- Lead Sponsor
- Changi General Hospital
- Brief Summary
This study aims to examine the use of Linked Color Imaging in detection of gastric cancer precursors, as well as oesophageal and duodenal lesions.
- Detailed Description
Gastric cancer is the fifth most common cause of death worldwide. Early detection and removal of gastric cancer precursors and early gastric cancer is crucial for good outcomes. However, these lesions are subtle and often missed by conventional white light imaging (WLI) endoscopy. Image enhanced endoscopy techniques have been developed to enhance the detection and characterization of gastrointestinal lesions. Narrow band imaging (NBI) is one such technique. Though widely used, its drawbacks include a limited far view as a result of the optical filter causing a dark endoscopic view. Linked color imaging (LCI) is a more recent image enhanced endoscopy technique that acquires images by using both narrow-band wavelength light and white light in an appropriate balance, enhancing slight color differences in the red region of mucosa. It has been proven to improve detection of H pylori gastritis and colorectal neoplasms. Thus far, there has been no study to determine whether the use of LCI will increase the detection rate of gastric cancer precursors and early gastric cancer compared to WLI. This study aims to determine whether LCI can increase the detection rate of gastric cancer precursors and early gastric cancer when compared to white light endoscopy, with the null hypothesis being no difference in detection rates. This study will also examine the use of LCI with magnification to predict histology findings for focal lesions seen on endoscopy, as well as the use of LCI in identifying esophageal lesions (such as Barett's esophagus) and duodenal lesions.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- Patients aged 50 years and above
- Patients undergoing gastroscopy for symptom evaluation
- Patients undergoing gastroscopy for surveillance of known intestinal metaplasia
- Emergent gastroscopy performed for suspected acute GI bleeding
- Patients with previous surgical/endoscopic resection in stomach
- Patients with deranged coagulation and platelet function (INR>1.5, Plt<50)
- Patients with severe comorbid illness (ASA 3 and above)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description White Light Imaging - Linked Color Imaging Linked Color Imaging Participant undergoes gastroscopy via White Light Imaging first, then followed by Linked Color Imaging White Light Imaging - Linked Color Imaging White Light Imaging Participant undergoes gastroscopy via White Light Imaging first, then followed by Linked Color Imaging Linked Color Imaging - White Light Imaging White Light Imaging Participant undergoes gastroscopy via Linked Color Imaging first, then followed by White Light Imaging Linked Color Imaging - White Light Imaging Linked Color Imaging Participant undergoes gastroscopy via Linked Color Imaging first, then followed by White Light Imaging
- Primary Outcome Measures
Name Time Method Difference in detection rate of oesophageal lesions between Linked Color Imaging and White Light Imaging Immediately following the procedure Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer
Difference in detection rate of gastric lesions between Linked Color Imaging and White Light Imaging Immediately following the procedure Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer
Difference in detection rate of duodenal lesions between Linked Color Imaging and White Light Imaging Immediately following the procedure Includes Duodenal adenoma, Duodenal adenocarcinoma
- Secondary Outcome Measures
Name Time Method Sensitivity and Specificity of detection of gastric lesions Upon histological confirmation - within 2 weeks of the procedure Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer
Sensitivity and Specificity of detection of oesophageal lesions Upon histological confirmation - within 2 weeks of the procedure Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer
Sensitivity and Specificity of detection of duodenal lesions Upon histological confirmation - within 2 weeks of the procedure Includes Duodenal adenoma, Duodenal adenocarcinoma
Trial Locations
- Locations (2)
Singapore General Hospital
🇸🇬Singapore, Singapore
Changi General Hospital
🇸🇬Singapore, Singapore